Your browser doesn't support javascript.
loading
Author Correction: Discovery of toxoflavin, a potent IRE1α inhibitor acting through structure-dependent oxidative inhibition.
Jiang, Kai-Long; Liu, Chang-Mei; Nie, Li-Tong; Jiang, Hai-Ni; Xu, Lei; Zhang, Kun-Zhi; Fan, Li-Xia; Gao, An-Hui; Lin, Lu-Lin; Wang, Xiang-Yu; Tan, Min-Jia; Zhang, Qi-Qing; Zhou, Yu-Bo; Li, Jia.
Afiliação
  • Jiang KL; Institute of Biomedical Engineering, The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), Shenzhen, 518020, China.
  • Liu CM; Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan, 528400, China.
  • Nie LT; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Jiang HN; University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Xu L; The First Affiliated Hospital, Jinan University, Guangzhou, 510632, China.
  • Zhang KZ; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Fan LX; School of Pharmaceutical Science, Jiangnan University, Wuxi, 214122, China.
  • Gao AH; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Lin LL; Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan, 528400, China.
  • Wang XY; School of Pharmacy, Zunyi Medical University, Zunyi, 563006, China.
  • Tan MJ; Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan, 528400, China.
  • Zhang QQ; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Zhou YB; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Li J; Zhejiang Center for Medical Device Evaluation, Zhejiang Medical Products Administration, Hangzhou, 311121, China.
Acta Pharmacol Sin ; 44(12): 2550, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37542201
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article